Cosmos Health Inc (COSM)

$0.75

-0.04

(-5.3%)

Live

Performance

  • $0.74
    $0.79
    $0.75
    downward going graph

    0.99%

    Downside

    Day's Volatility :5.69%

    Upside

    4.75%

    downward going graph
  • $0.47
    $1.65
    $0.75
    downward going graph

    37.64%

    Downside

    52 Weeks Volatility :71.65%

    Upside

    54.55%

    downward going graph

Returns

PeriodCosmos Health IncIndex (Russel 2000)
3 Months
-30.49%
0.0%
6 Months
61.38%
0.0%
1 Year
-22.31%
0.0%
3 Years
-99.08%
-23.0%

Highlights

Market Capitalization
14.1M
Book Value
$1.81
Earnings Per Share (EPS)
-2.28
PEG Ratio
0.0
Wall Street Target Price
4.0
Profit Margin
-38.19%
Operating Margin TTM
-18.95%
Return On Assets TTM
-20.23%
Return On Equity TTM
-56.61%
Revenue TTM
56.5M
Revenue Per Share TTM
3.73
Quarterly Revenue Growth YOY
6.800000000000001%
Gross Profit TTM
8.3M
EBITDA
-19.9M
Diluted Eps TTM
-2.28
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.48
EPS Estimate Next Year
-0.05
EPS Estimate Current Quarter
-0.14
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Cosmos Health Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 433.33%

Current $0.75
Target $4.00

Company Financials

FY18Y/Y Change
Revenue
37.1M
↑ 23.56%
Net Income
-9.1M
↑ 45.91%
Net Profit Margin
-24.43%
↓ 3.74%
FY19Y/Y Change
Revenue
39.7M
↑ 6.99%
Net Income
-3.3M
↓ 63.59%
Net Profit Margin
-8.31%
↑ 16.12%
FY20Y/Y Change
Revenue
55.4M
↑ 39.65%
Net Income
820.8K
↓ 124.88%
Net Profit Margin
1.48%
↑ 9.79%
FY21Y/Y Change
Revenue
56.2M
↑ 1.5%
Net Income
-8.0M
↓ 1070.0%
Net Profit Margin
-14.16%
↓ 15.64%
FY22Y/Y Change
Revenue
50.3M
↓ 10.48%
Net Income
-13.8M
↑ 73.71%
Net Profit Margin
-27.47%
↓ 13.31%
FY23Y/Y Change
Revenue
53.4M
↑ 6.02%
Net Income
-18.5M
↑ 34.07%
Net Profit Margin
-34.74%
↓ 7.27%
Q1 FY23Q/Q Change
Revenue
12.3M
↑ 2.48%
Net Income
-459.9K
↓ 95.75%
Net Profit Margin
-3.72%
↑ 86.06%
Q2 FY23Q/Q Change
Revenue
12.4M
↑ 0.11%
Net Income
-981.5K
↑ 113.44%
Net Profit Margin
-7.94%
↓ 4.22%
Q3 FY23Q/Q Change
Revenue
12.8M
↑ 3.72%
Net Income
-3.3M
↑ 241.22%
Net Profit Margin
-26.12%
↓ 18.18%
Q4 FY23Q/Q Change
Revenue
15.8M
↑ 23.52%
Net Income
-13.8M
↑ 310.61%
Net Profit Margin
-86.82%
↓ 60.7%
Q1 FY24Q/Q Change
Revenue
14.6M
↓ 7.93%
Net Income
-1.9M
↓ 86.43%
Net Profit Margin
-12.8%
↑ 74.02%
Q2 FY24Q/Q Change
Revenue
13.2M
↓ 9.45%
Net Income
-2.6M
↑ 38.79%
Net Profit Margin
-19.62%
↓ 6.82%
FY18Y/Y Change
Total Assets
20.7M
↑ 93.85%
Total Liabilities
24.0M
↑ 75.23%
FY19Y/Y Change
Total Assets
23.9M
↑ 15.39%
Total Liabilities
30.3M
↑ 26.35%
FY20Y/Y Change
Total Assets
43.8M
↑ 83.61%
Total Liabilities
48.0M
↑ 58.22%
FY21Y/Y Change
Total Assets
49.4M
↑ 12.74%
Total Liabilities
45.0M
↓ 6.16%
FY22Y/Y Change
Total Assets
68.0M
↑ 37.65%
Total Liabilities
28.4M
↓ 37.0%
FY23Y/Y Change
Total Assets
66.0M
↓ 2.97%
Total Liabilities
30.0M
↑ 5.6%
Q1 FY23Q/Q Change
Total Assets
68.0M
↓ 0.03%
Total Liabilities
23.6M
↓ 16.72%
Q2 FY23Q/Q Change
Total Assets
68.6M
↑ 0.85%
Total Liabilities
24.6M
↑ 3.87%
Q3 FY23Q/Q Change
Total Assets
71.5M
↑ 4.28%
Total Liabilities
27.0M
↑ 9.8%
Q4 FY23Q/Q Change
Total Assets
66.0M
↓ 7.7%
Total Liabilities
30.0M
↑ 11.18%
Q1 FY24Q/Q Change
Total Assets
62.3M
↓ 5.56%
Total Liabilities
27.8M
↓ 7.25%
Q2 FY24Q/Q Change
Total Assets
60.8M
↓ 2.43%
Total Liabilities
28.7M
↑ 3.27%
FY18Y/Y Change
Operating Cash Flow
-1.6M
↓ 82.25%
Investing Cash Flow
-195.8K
↑ 1252.11%
Financing Cash Flow
2.0M
↓ 78.6%
FY19Y/Y Change
Operating Cash Flow
-4.8M
↑ 207.9%
Investing Cash Flow
588.9K
↓ 400.82%
Financing Cash Flow
3.6M
↑ 80.42%
FY20Y/Y Change
Operating Cash Flow
-11.5M
↑ 140.18%
Investing Cash Flow
-117.7K
↓ 119.99%
Financing Cash Flow
12.5M
↑ 247.35%
FY21Y/Y Change
Operating Cash Flow
-7.1M
↓ 38.29%
Investing Cash Flow
-826.8K
↑ 602.22%
Financing Cash Flow
7.3M
↓ 41.67%
Q1 FY23Q/Q Change
Operating Cash Flow
-10.3M
↑ 80.39%
Investing Cash Flow
-4.5M
↑ 13.26%
Financing Cash Flow
30.6M
↑ 1263.05%
Q2 FY23Q/Q Change
Operating Cash Flow
-5.7M
↓ 44.57%
Investing Cash Flow
-4.0M
↓ 11.71%
Financing Cash Flow
-184.2K
↓ 100.6%

Technicals Summary

Sell

Neutral

Buy

Cosmos Health Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cosmos Health Inc
Cosmos Health Inc
-21.54%
61.38%
-22.31%
-99.08%
-99.08%
Cardinal Health, Inc.
Cardinal Health, Inc.
0.51%
9.32%
22.2%
129.13%
122.99%
Cencora Inc
Cencora Inc
3.99%
0.24%
25.74%
62.86%
96.16%
Mckesson Corporation
Mckesson Corporation
0.83%
-3.44%
13.16%
145.76%
245.57%
Henry Schein, Inc.
Henry Schein, Inc.
1.06%
0.49%
7.39%
-8.38%
15.09%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cosmos Health Inc
Cosmos Health Inc
NA
NA
0.0
-0.48
-0.57
-0.2
NA
1.81
Cardinal Health, Inc.
Cardinal Health, Inc.
32.58
32.58
0.96
7.36
0.0
0.03
0.02
-13.17
Cencora Inc
Cencora Inc
25.59
25.59
1.33
13.63
1.88
0.03
0.01
4.7
Mckesson Corporation
Mckesson Corporation
22.73
22.73
1.48
27.59
0.0
0.04
0.01
-13.53
Henry Schein, Inc.
Henry Schein, Inc.
26.45
26.45
1.6
4.75
0.07
0.04
NA
27.64
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cosmos Health Inc
Cosmos Health Inc
Buy
$14.1M
-99.08%
NA
-38.19%
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$27.2B
122.99%
32.58
0.38%
Cencora Inc
Cencora Inc
Buy
$46.2B
96.16%
25.59
0.65%
Mckesson Corporation
Mckesson Corporation
Buy
$66.0B
245.57%
22.73
0.94%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.1B
15.09%
26.45
2.82%

Insights on Cosmos Health Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 15.83M → 13.20M (in $), with an average decrease of 8.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.86M → -2.59M (in $), with an average decrease of 38.8% per quarter

  • Vs COR

    In the last 1 year, Cencora Inc has given 25.8% return, outperforming this stock by 48.9%

Institutional Holdings

  • BlackRock Inc

    1.51%
  • Vanguard Group Inc

    0.76%
  • Geode Capital Management, LLC

    0.70%
  • State Street Corp

    0.14%
  • Northern Trust Corp

    0.12%
  • Group One Trading, LP

    0.06%

Company Information

Organization
Cosmos Health Inc
Employees
123
CEO
Mr. Grigorios Siokas
Industry
Miscellaneous

FAQs